SRF Stock Analyzed
SRF, a company that makes chemicals and other cool stuff, is getting good reviews from financial experts. They’re generally positive, but they’re looking closely at some things. Let’s break down what the experts are saying about SRF’s business.
Key Points
- SRF profits jumped significantly in Q3FY26.
- Growth is driven by refrigerants and fluorochemicals.
- Specialty chemicals face challenges due to weaker demand.
- Brokerages like Emkay, Elara, and MOFSL have ‘Buy’, ‘Accumulate’, and ‘Add’ ratings.
- SRF is investing heavily in new factories.
- Strong demand for refrigerants is a key positive factor.
SRF made a lot more money in the last three months (Q3FY26) compared to the same time last year – a big jump of 59.6%. They also sold more stuff (revenue went up 6.3%) and their operations were running more efficiently (Ebitda increased by 22.2%). However, some of their products, especially the specialty chemicals, weren’t doing as well because some large companies weren’t buying them as quickly, and competitors were lowering prices.
The good news is that the part of SRF that makes refrigerants and fluorochemicals was doing really well. This was because people were buying more of those things, both in India and around the world. They’re also building a new factory in Odisha, which should help them grow even more.
Here’s what the financial experts think: Emkay Global gave SRF a ‘Buy’ rating and a target price of ₹3,250, saying they need to watch out for some challenges. Elara Capital also said ‘Accumulate’ and lowered their target price to ₹3,258, focusing on the strong demand for refrigerants. Motilal Oswal Financial Services (MOFSL) stayed ‘Buy’ with a target of ₹3,660, highlighting the company’s good growth prospects.
Ultimately, SRF’s future depends on successfully navigating these market challenges and continuing to innovate.
